On Oct 23, Lei Ping, deputy commissioner of China's National Medical Products Administration (NMPA), met with a delegation led by Dmitry Pavlyukov, deputy head of the Federal Service for Surveillance in Healthcare of the Russian Federation (Roszdravnadzor).

Lei briefed the Russian side on China's reform of the medical device review and approval system, the development of its regulatory framework and standards, whole-life-cycle regulation and industrial innovation and development. He said that the drug regulatory authorities of China and Russia have long maintained friendly relations, and that China is willing to further strengthen communication and exchanges with Russia to promote the steady development of regulatory cooperation between the two countries.

Pavlyukov introduced the medical device regulatory work of the Federal Service for Surveillance in Healthcare of the Russian Federation and expressed the hope to further strengthen exchanges in areas such as medical device registration management and post-market surveillance.

Both sides agreed to further enhance international regulatory cooperation and jointly improve regulatory capacity and effectiveness to ensure the safe use of medical devices by the public in both countries.

Heads of relevant departments and affiliated institutions of the NMPA were also present.